Covid -19 has changed the data privacy paradigm. What used to be controversial with regards to accessing and mining large data sets with Business Associate Agreements (BAA), due to ensuing consumer privacy backlash is beginning to become more acceptable. While we are still at baby
The JP Morgan Health Conference was a great week in regards to meetings in the digital health and biotech ecosystem. As mentioned in Modern Healthcare, it’s the week where one can make enough contacts to hold over for a year! Well, that’s a bit of
Much is talked about health care distribution channels such as payers here in the US. Yet just across the atlantic, there is a payer that is just as important especially when it comes to testing new AI ideas – the UK National Health Service (NHS).
Livongo and Health Catalyst made the public markets late last month, showcasing how the market in terms of VC and customer acquisition for B2B healthcare and the wider tech industry will likely adapt. On the surface both companies may look like healthcare companies but on
The World Medical Innovation Forum in Boston just wrapped after three days of insights on artificial intelligence in health care. While it didn’t disappoint in respect to buzzwords as is expected in AI conferences, it was the quality of the participants and their views on
Considering the launch of a Bayer campaign back in 2016 reported by Fierce Pharma, Facebook has been building teams that sell pharma ads to the health care sector. While still in the early stages, it is no secret that Google built those teams years ago